Ingrid Teigland Akay

Ingrid Teigland Akay is the Founder and Managing Partner of Hadean Ventures, a European life science fund manager with a focus on the Nordic region. Ingrid Teigland is also a Board Member at Alex Therapeutics, Invest Europe, Neuro Event Labs Oy, Attgeno AB, and has previously served on the boards of Oncoinvent AS, Norges forskningsråd, Norwegian Venture Capital & Private Equity Association (NVCA), Gentian Technology AS, and Sonitor Technologies. In terms of education, Ingrid Teigland earned an MBA in Finance from London Business School and holds a BA in German and History from the University of Oslo.